Tele: 561.316.3330
Breaking Medical Device News

Wednesday, September 22, 2021
HomeCanon Medical Systems USACanon Medical Partners With Surfacide to Provide Rapid Decontamination Solution for Imaging Systems

Canon Medical Partners With Surfacide to Provide Rapid Decontamination Solution for Imaging Systems

UV-C Decontamination Technology Can Decontaminate Imaging Equipment of Viral Infectious Diseases in Minutes

Hospitals and institutions are regularly using imaging as a frontline tool for triaging patients, and disinfection after use can be time-consuming when every second counts. To meet the need for fast decontamination, Canon Medical Systems USA, Inc. has partnered with Surfacide to offer Helios – a rapid decontamination tool for its imaging equipment.

The Surfacide Helios system provides an automated UV-C decontamination technology that significantly reduces bacteria, spores and viruses and is effective against a variety of advanced viral infectious diseases. Helios incorporates multiple automated UV-C emitters that work together to provide decontamination of the room in minutes to help improve workflow.

“At Canon Medical, our priority is to support our customers and their patients by providing them not only with innovative imaging systems, but also the latest technology advancements that can impact their outcomes and workflow,” said Satrajit Misra, vice president, Marketing and Strategic Development, Canon Medical Systems USA, Inc. “In the current healthcare climate, partnering with Surfacide to offer a solution that can quickly, easily and effectively decontaminate an imaging system can help hospitals and institutions manage their high throughput and keep patients safe by helping to prevent the spread of infection.”

“Today, two innovative technology leaders are focused on making imaging suites and hospitals safer for hospital healthcare workers and patients,” says Gunner Lyslo, Founder & CEO of Surfacide LLC. “Surfacide and Canon Medical are coming together at an urgent time when safety and infection prevention is paramount throughout the world. Surfacide and its multi-emitter UV-C technology will fight infectious diseases and decontaminate surfaces to create a much safer environment for patients and healthcare workers when it is needed the most.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

Kleiner Device Labs Receives FDA Market Clearance for KG2 Surge Flow-Thru Interbody System

The system maximizes total bone graft delivery volume, better distributes graft bilaterally into the intervertebral disc space, and streamlines the implant delivery, positioning, and grafting process for TLIF and PLIF spinal fusion procedures.

Matthew Cranfill New ExtriCARE USA Director Of Clinical Services

"Matt's impressive experience and skillset easily made him our top pick," said Peter Mason, President of ExtriCARE USA.

FDA Authorizes Software that Can Help Identify Prostate Cancer

The software is called Paige Prostate and is compatible for use with slide images that have been digitized using a scanner.

Shannon Lantzy MedCrypt New VP of Consulting

"I met Shannon at a healthcare-related event several years ago and was immediately impressed with her passion and drive to move healthcare into a digital future," said Mike Kijewski, CEO of MedCrypt.

Mark Foster Joins Xenocor BOD

Foster is a versatile and visionary C-Suite executive who brings 20 years of general management and leadership experience from both venture-backed growth-stage organizations and world-class medical device companies

Hinge Health Acquires the Most Advanced Computer Vision Technology for Tracking Human Motion

CEO Daniel Perez explained, “We won’t stop investing in technology to deliver the most patient-centered digital clinic that improves member experience and outcomes while reducing costs. wrnch allows us to take a giant leap forward in all respects.”

Dale W Wood Congratulates the Huma Team on Raising $130 Million

Major health and technology companies across the world have committed upwards of $130 million to Huma Therapeutics, the health-tech company backed by Dale Ventures.

Rhaeos Awarded $4 Million NIH SBIR Grant

Under the NIH SBIR grant, Rhaeos will leverage their existing wireless sensor hardware to provide additional quantitative flow data to the clinician, giving insight into this currently inaccessible and highly relevant shunt performance metric.

By using this website you agree to accept Medical Device News Magazine Privacy Policy